Abstract
Guillain-Barre syndrome is an acute inflammatory polyradiculoneuropathy characterized by progressive symmetric weakness of distal onset associated with areflexia and mild sensory symptoms. The AMAN variant is a rare entity in Latin America. The case of a 6-year-old male patient, previously healthy, with a diagnosis of Guillain-Barre Syndrome, axonal variant, secondary to upper airway symptoms, is reported. The importance of the report lies in informing the pediatrician and other health professionals about the existence of this entity and thus increasing the diagnostic suspicion considering its low incidence. We also highlight the possibility of finding variability in the typical clinical forms of presentation, as was the case presented, since it is a subtype of the disease that is classically characterized as severe and with torpid evolution. It is also associated with frequent sequelae.
References
Pascual Pascual SI. Síndrome GuiUain Barré. Madrid: Asociación Española de Pediatría; 2008.
Lee KS, Han SH. Acute motor axonal neuropathy in a child with atypical presentation: a case report. Medicine (Baltimore). 2015;94(3):e392. doi: 10.1097/MD.0000000000000392.
Buompadre MC, Gáñez LA, Miranda M, Arroyo HA. Variantes inusuales del síndrome de Guillain-Barré en la infancia. Rev Neurol. 2006;42(2):85-90.
Ramírez-Zamora M, Burgos-Ganuza CR, Alas-Valle DA, Vergara-Galán PE, Ortez-González CI. Síndrome de Guillain-Barré en edad pediátrica. Perfil epidemiológico, clínico y terapéutico en un hospital de El Salvador. Rev Neurol. 2009;48(6):292-6.
Lestayo-O'Farrill Z, Hernández-Cáceres JL. Análisis del comportamiento del síndrome de Guillain-Barré. Consensos y discrepancias. Rev Neurol. 2008;46(4):230-7.
Ashrafi MR, Mohammadalipoor A, Naeini AR, Amanat M, Tavasoli AR, Heidari M, et al. Clinical characteristics and elec trodiagnostic features of Guillain-Barré Syndrome among the pediatric population. J Child Neurol. 2020;35(7):448-55. doi: 10.1177/0883073820905157.
Shang P, Zhu M, Wang Y, Zheng X, Wu X, Zhu J, et al. Axonal variants of Guillain-Barré syndrome: an update. J Neurol. 2020; doi: 10.1007/s00415-020-09742-2.
Goodfellow JA, Willison HJ. Antiganglioside, antiganglioside complex, and antiglycolipid-complex antibodies in immune mediated neuropathies. Curr Opin Neurol. 2016;29(5):572-80. doi: 10.1097/WCO.0000000000000361.
Cavalcante JB, Cembraneli PN, Cavalcante RB, Junior VF, Cavalcante JE. Atypical manifestations in children with Guillain-Barré syndrome. Edorium J Neurol. 2020;7:100014N06JC2020. doi: 10.5348/100014N06JC2020CR.
van Doorn PA. Diagnosis, treatment and prognosis of Guillain Barré syndrome (GBS). Presse Med. 2013;42(6 Pt 2):e193-e201. doi: 10.1016/j.lpm.2013.02.328.
Taboada R, González G, García A, Alberti M, Scavone C. Protocolo diagnóstico y terapéutico del síndrome de Guillain Barré. Arch Pediatr Urug. 2008; 79(1).
Pérez JC, Síndrome de Guillain-Barré (SGB) Actualización. Acta Neurol Colomb. 2006;22:201-8.
Varkal MA, Uzunhan TA, Aydinli N, Ekici B, Çaliskan M, Ozmen M. Pediatric Guillain-Barré syndrome: Indicators for a severe course. Ann Indian Acad Neurol. 2015;18(1):24-8. doi: 10.4103/0972-2327.144274.
Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol. 1998;44(5):780-8. doi: 10.1002/ana.410440512.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.